StockData
Silence Therapeutics plc logo

Silence Therapeutics plc (SLN) stock

SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$19.80+0.00 (0.00%)

Close on Nov 17, 2026Market cap $935.48MP/E –Yield –

Silence Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Silence Therapeutics's enterprise value was $861.96M on Nov 11, 2026, against $216.16M a year earlier. Over the last 5 years it ranged from -$14.13M to $940.22M, with a median of $341.57M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$861.96M+366.0%
2025Dec 31, 2025$184.99M-9.2%
2024Dec 31, 2024$203.77M-67.4%
2023Dec 29, 2023$624.21M+38.0%
2022Dec 30, 2022$452.16M-30.6%
2021Dec 31, 2021$651.18M+18.2%
2020Dec 31, 2020$550.93M–

More Silence Therapeutics figures

See a number that looks wrong?